Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ETB-DualNK-01
- Development stage
- Phase 1
- Lead developer
- Beijing Biotech
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
ETB-DualNK-01 is an allogeneic, dual-target chimeric antigen receptor natural killer (CAR-NK) cell therapy developed by Beijing Biotech. It is engineered to express CARs targeting both Prostate-Specific Membrane Antigen (PSMA) and Prostate Stem Cell Antigen (PSCA), which are highly expressed in prostate cancer. As an allogeneic 'off-the-shelf' product, it utilizes NK cells from healthy donors, potentially offering advantages over autologous CAR-T therapies, such as reduced risk of graft-versus-host disease and immediate availability. It is currently in Phase 1 development for metastatic castration-resistant prostate cancer (mCRPC).
02
Targets
PSCA (Prostate stem cell antigen)
Beyond the preview
Go deeper on ETB-DualNK-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ETB-DualNK-01.